Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Binimetinib and Imatinib in Advanced KIT-Mutant Melanoma
NCT04598009Phase 2Recruiting
- Sponsor
- University of California, San Francisco
- Start
- Mar 2021
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 2 trial of binimetinib in melanoma, sponsored by University of California, San Francisco. Started Mar 2021; status: recruiting.
02
Drugs
binimetinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT04598009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04598009.